Literature DB >> 6292392

Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung.

J Latifpour, S B Jones, D B Bylund.   

Abstract

In contrast to the adult rat lung, which lacks alpha-2 adrenergic receptor binding sites, the neonatal rat lung had a high density of [3H]yohimbine binding sites. The binding of this alpha-2 antagonist was saturable, reversible and stereospecific. Steady-state binding was reached by 15 min at 23 degrees C, and the association and dissociation rate constants were 0.17 min-1nM-1 and 0.30 min-1, respectively. From saturation experiments, a Bmax of 304 fmol/mg of protein and a KD of 1.53 nM were calculated. Surprisingly, no appreciable specific binding was observed in this tissue for the alpha-2 agonists [3H]clonidine, [3H]paraminoclonidine and [3H]epinephrine. Inhibition experiments indicated that the binding site had the characteristics of an alpha-2 adrenergic receptor although yohimbine was only 5 times more potent than prazosin. The Ki for epinephrine was decreased 4-fold by 100 microM guanyl-5'-6'-imidodiphosphate suggesting that the receptor binding site may be coupled to adenylate cyclase. Ethanol inhibited the [3H]yohimbine binding with an IC50 of 200 mM. This inhibition was "competitive-like" as increasing concentrations of ethanol resulted in an increased KD, but not a decrease in Bmax. The presence of high density [3H]yohimbine binding sites in early life may have a developmental importance which is not yet understood.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292392

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Adrenoceptor- and cholinoceptor-mediated mechanisms in the regulation of 5-hydroxytryptamine release from isolated tracheae of newborn rabbits.

Authors:  A Freitag; I Wessler; K Racké
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Alpha-adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production.

Authors:  P E Hicks; M Barras; G Herman; P Mauduit; J M Armstrong; B Rossignol
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

Review 3.  Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively?

Authors:  Ralf Gilsbach; Lutz Hein
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  [3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species.

Authors:  C B Neylon; R J Summers
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

5.  Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes.

Authors:  G Maura; G Bonanno; M Raiteri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

6.  [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.

Authors:  A C MacKinnon; A T Kilpatrick; B A Kenny; M Spedding; C M Brown
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

7.  Activities of octopamine and synephrine stereoisomers on alpha-adrenoceptors.

Authors:  C M Brown; J C McGrath; J M Midgley; A G Muir; J W O'Brien; C M Thonoor; C M Williams; V G Wilson
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

8.  Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.

Authors:  C M Brown; A C MacKinnon; J C McGrath; M Spedding; A T Kilpatrick
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

9.  Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.

Authors:  C M Brown; A C MacKinnon; J C McGrath; M Spedding; A T Kilpatrick
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

10.  Comparison of potency of alpha 2-adrenoceptor antagonists in vitro: evidence for heterogeneity of alpha 2-adrenoceptors.

Authors:  V A Alabaster; R F Keir; C J Peters
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.